This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Jean-Paul Kleeven
Introduction
Jean-Paul Kleeven is a notable inventor based in Wijchen, Netherlands. He has made significant contributions to the field of medical devices, particularly in the area of injection technology. His innovative work has led to the development of a unique injection device that enhances the delivery of solutions in a precise manner.
Latest Patents
Kleeven holds a patent for an "Injection device and injection solution transferring system." This invention focuses on a micro dose injection device, such as an ophthalmic injection device. The device features a rotatable plunger and a solution receptacle designed to dispense the solution effectively. The design includes mechanisms to prevent unwanted movement and rotation of the plunger, ensuring accurate dosing.
Career Highlights
Jean-Paul Kleeven is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to advancements in medical technology, particularly in the development of innovative injection systems. His patent reflects his commitment to improving patient care through better medical devices.
Collaborations
Kleeven has collaborated with notable colleagues, including Frederick William Hamlin and Anthony Jonathan Bedford. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical technology.
Conclusion
Jean-Paul Kleeven's contributions to the field of injection devices exemplify the importance of innovation in healthcare. His patent for a micro dose injection device showcases his dedication to improving medical solutions. Through his work at Novartis AG and collaborations with esteemed colleagues, Kleeven continues to make a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
